Novo Nordisk Says Fed Drug Pricing Unseen Even In Wartime
Novo Nordisk Inc. urged a New Jersey federal judge to grant it a win in its challenge to the Medicare drug price negotiation program, taking on both the Inflation Reduction Act's...To view the full article, register now.
Already a subscriber? Click here to view full article